vesnarinone has been researched along with Myocarditis in 5 studies
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Myocarditis was induced in 30 Lewis rats by injection of porcine cardiac myosin and vesnarinone was orally administered to 20 of the 30 rats." | 7.70 | Inhibitory effects of vesnarinone in the progression of myocardial damage in experimental autoimmune myocarditis in rats. ( Hiroe, M; Hosokawa, T; Ikeda, I; Ishiyama, S; Kasajima, T; Marumo, F; Nishikawa, T; Shimojo, T; Toyozaki, T, 1999) |
| "Myocarditis was induced in 30 Lewis rats by injection of porcine cardiac myosin and vesnarinone was orally administered to 20 of the 30 rats." | 3.70 | Inhibitory effects of vesnarinone in the progression of myocardial damage in experimental autoimmune myocarditis in rats. ( Hiroe, M; Hosokawa, T; Ikeda, I; Ishiyama, S; Kasajima, T; Marumo, F; Nishikawa, T; Shimojo, T; Toyozaki, T, 1999) |
| "Myocarditis is thought to be caused by various viruses, and accumulating evidence links viral myocarditis with the eventual development of dilated cardiomyopathy." | 2.39 | Cytokines in myocarditis and cardiomyopathies. ( Matsumori, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sasayama, S | 3 |
| Matsumori, A | 3 |
| Ishiyama, S | 1 |
| Hiroe, M | 1 |
| Nishikawa, T | 1 |
| Shimojo, T | 1 |
| Hosokawa, T | 1 |
| Ikeda, I | 1 |
| Toyozaki, T | 1 |
| Kasajima, T | 1 |
| Marumo, F | 1 |
| Inoue, M | 1 |
| Asanoi, H | 1 |
| Kodama, K | 1 |
| Hori, M | 1 |
| Sakurai, T | 1 |
| Kawai, C | 1 |
2 reviews available for vesnarinone and Myocarditis
| Article | Year |
|---|---|
Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.
Topics: Adjuvants, Immunologic; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; B | 1995 |
Cytokines in myocarditis and cardiomyopathies.
Topics: Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Cytokines; Heart Injuries; Hepatitis C; Humans | 1996 |
3 other studies available for vesnarinone and Myocarditis
| Article | Year |
|---|---|
Role of cytokines in the syndrome of heart failure.
Topics: Adrenergic beta-Agonists; Amrinone; Animals; Cardiotonic Agents; Cytokines; Heart Failure; Humans; K | 1996 |
Inhibitory effects of vesnarinone in the progression of myocardial damage in experimental autoimmune myocarditis in rats.
Topics: Analysis of Variance; Animals; Autoimmune Diseases; Biomarkers; Blotting, Northern; Female; Interleu | 1999 |
Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Coro | 1986 |